AArtificial intelligence Read More AI is exposing cracks in India’s growth story as it hits high-paying IT jobsApril 30, 2026 Hello, this is Priyanka Salve, writing to you from Singapore. Welcome to the latest edition of “Inside India” — your…
HHealthcare Read More Eli Lilly (LLY) earnings Q1 2026April 30, 2026 Eli Lilly on Thursday reported first-quarter earnings and revenue that blew past estimates and hiked its full-year sales…
AArtificial intelligence Read More Novo Nordisk partners with OpenAI as AI drug discovery hopes mount April 14, 2026 People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in…
MMedication Read More Stitch Fix, apparel retailers may benefitApril 9, 2026 Michelle Suter has worn mostly big and baggy clothing for years. The 63-year-old retiree who lives in a…
EEconomy Read More Tariffs and Iran war threaten India’s $100 billion garments export goalApril 9, 2026 Hello, this is Priyanka Salve, writing to you from Singapore. Welcome to the latest edition of “Inside India”…
EEconomy Read More China Development Forum welcomes U.S. execs revamping market pushMarch 23, 2026 Apple CEO Tim Cook (L) stands with Siemens CEO Roland Busch prior to the opening ceremony of the…
MMedication Read More FDA approves high dose version of Novo Nordisk’s obesity drug WegovyMarch 22, 2026 The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark,…
MMedication Read More Restaurants add protein, fiber for weight loss drug usersMarch 21, 2026 A mini burger, mini fries and mini beer, Clinton Hall’s “Teeny Weeny Mini Meal”, is pictured next to…
BBusiness Read More Zealand stock plummets after trial setback, CEO remains optimisticMarch 7, 2026 Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management…
HHealthcare Read More Eli Lilly launches program to boost employer coverage of obesity drugsMarch 5, 2026 Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the…
HHealthcare Read More Why Novo Nordisk’s Ireland expansion is key to fighting off Eli LillyMarch 2, 2026 Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its…
HHealthcare Read More What’s next for Novo Nordisk’s obesity drug CagriSemaFebruary 24, 2026 A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news…